{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:32Z","timestamp":1792601552894,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0091"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0091"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07302-8","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:39:40Z","timestamp":1763138380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MPTP mediated Ox-mtDNA release inducing macrophage pyroptosis and exacerbating MCD-induced MASH via promoting the ITPR3\/Ca2+\/NLRP3 pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-1363","authenticated-orcid":false,"given":"Sheng-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"7302_CR1","doi-asserted-by":"crossref","unstructured":"Wang X, Zhang L, Dong B. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology. 2024.","DOI":"10.1097\/HEP.0000000000000786"},{"key":"7302_CR2","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts, 2024;17(4):374\u2013444.","DOI":"10.1159\/000539371"},{"key":"7302_CR3","doi-asserted-by":"publisher","first-page":"1569915","DOI":"10.3389\/fimmu.2025.1569915","volume":"16","author":"Q Wu","year":"2025","unstructured":"Wu Q, et al. The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC. Front Immunol. 2025;16:1569915.","journal-title":"Front Immunol"},{"issue":"5","key":"7302_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","volume":"36","author":"MA Tincopa","year":"2024","unstructured":"Tincopa MA, Anstee QM, Loomba R. New and emerging treatments for metabolic dysfunction-associated steatohepatitis. Cell Metab. 2024;36(5):912\u201326.","journal-title":"Cell Metab"},{"key":"7302_CR5","doi-asserted-by":"publisher","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","volume":"11","author":"C Luci","year":"2020","unstructured":"Luci C, et al. Chronic inflammation in Non-Alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies. Front Endocrinol (Lausanne). 2020;11:597648.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"7302_CR6","doi-asserted-by":"publisher","first-page":"e70191","DOI":"10.1002\/hsr2.70191","volume":"7","author":"M Torabizadeh","year":"2024","unstructured":"Torabizadeh M, et al. The association of nasal and blood eosinophils with serum IgE level in allergic rhinitis and asthma: A Case-Control study. Health Sci Rep. 2024;7(11):e70191.","journal-title":"Health Sci Rep"},{"key":"7302_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fendo.2020.00259","volume":"11","author":"A Remmerie","year":"2020","unstructured":"Remmerie A, Martens L, Scott CL. Macrophage subsets in Obesity, aligning the liver and adipose tissue. Front Endocrinol (Lausanne). 2020;11:259.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7302_CR8","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fimmu.2019.01192","volume":"10","author":"C Luci","year":"2019","unstructured":"Luci C, et al. Natural killer cells and type 1 innate lymphoid cells are new actors in Non-alcoholic fatty liver disease. Front Immunol. 2019;10:1192.","journal-title":"Front Immunol"},{"issue":"3","key":"7302_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.28389","volume":"63","author":"AC Tosello-Trampont","year":"2016","unstructured":"Tosello-Trampont AC, et al. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. Hepatology. 2016;63(3):799\u2013812.","journal-title":"Hepatology"},{"issue":"2","key":"7302_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"7302_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145\u201359.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"7302_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10238-025-01588-0","volume":"25","author":"A Raoufi","year":"2025","unstructured":"Raoufi A, et al. Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets. Clin Exp Med. 2025;25(1):73.","journal-title":"Clin Exp Med"},{"issue":"1","key":"7302_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","volume":"56","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. Immunity. 2023;56(1):58\u2013e7711.","journal-title":"Immunity"},{"issue":"2","key":"7302_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke F, et al. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol. 2023;79(2):552\u201366.","journal-title":"J Hepatol"},{"issue":"1","key":"7302_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74(1):156\u201367.","journal-title":"J Hepatol"},{"issue":"5","key":"7302_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, et al. NLRP3 inflammasome Blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 2017;66(5):1037\u201346.","journal-title":"J Hepatol"},{"issue":"11","key":"7302_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2174\/0929866529666220829152631","volume":"29","author":"Q Xiang","year":"2022","unstructured":"Xiang Q, Fu CJ, Li XH. The molecular mechanism of CoenzymeQ10 on pyroptosis and its related diseases: A review. Protein Pept Lett. 2022;29(11):911\u20136.","journal-title":"Protein Pept Lett"},{"issue":"9","key":"7302_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327.","journal-title":"Cell Mol Immunol"},{"key":"7302_CR19","doi-asserted-by":"crossref","unstructured":"Li S et al. NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight, 2021;6(23).","DOI":"10.1172\/jci.insight.146852"},{"issue":"5","key":"7302_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V, et al. Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol. 2024;81(5):895\u2013910.","journal-title":"J Hepatol"},{"key":"7302_CR21","doi-asserted-by":"publisher","first-page":"1218807","DOI":"10.3389\/fcell.2023.1218807","volume":"11","author":"C Stoess","year":"2023","unstructured":"Stoess C, et al. Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis. Front Cell Dev Biol. 2023;11:1218807.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"7302_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55(8):1370\u2013e13858.","journal-title":"Immunity"},{"issue":"39","key":"7302_CR23","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","volume":"20","author":"G Paradies","year":"2014","unstructured":"Paradies G, et al. Oxidative stress, Cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(39):14205\u201318.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"7302_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli S, et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J Exp Med. 2016;213(5):697\u2013713.","journal-title":"J Exp Med"},{"issue":"3","key":"7302_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/1570159X20666220810114644","volume":"21","author":"D Shang","year":"2023","unstructured":"Shang D, et al. mtDNA maintenance and alterations in the pathogenesis of neurodegenerative diseases. Curr Neuropharmacol. 2023;21(3):578\u201398.","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"7302_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/intimm\/dxab016","volume":"33","author":"SPM Sok","year":"2021","unstructured":"Sok SPM, et al. 1\u2019-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression. Int Immunol. 2021;33(7):373\u201386.","journal-title":"Int Immunol"},{"issue":"1","key":"7302_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41420-024-01840-8","volume":"10","author":"QR Wu","year":"2024","unstructured":"Wu QR, et al. IP3R2-mediated Ca(2+) release promotes LPS-induced cardiomyocyte pyroptosis via the activation of NLRP3\/Caspase-1\/GSDMD pathway. Cell Death Discov. 2024;10(1):91.","journal-title":"Cell Death Discov"},{"key":"7302_CR28","doi-asserted-by":"crossref","unstructured":"Piamsiri C et al. Potential roles of IP(3) receptors and calcium in programmed cell death and implications in cardiovascular diseases. Biomolecules, 2024;14(10).","DOI":"10.3390\/biom14101334"},{"key":"7302_CR29","doi-asserted-by":"crossref","unstructured":"Alshawsh MA et al. A comparison of the gene expression profiles of non-alcoholic fatty liver disease between animal models of a high-fat diet and methionine-choline-deficient diet. Molecules. 2022;27(3).","DOI":"10.3390\/molecules27030858"},{"key":"7302_CR30","doi-asserted-by":"crossref","unstructured":"Pi D et al. Atractylodes lancea rhizome polysaccharide alleviates MCD Diet-Induced NASH by inhibiting the p53\/mTOR pathway. Int J Mol Sci, 2024;25(20).","DOI":"10.3390\/ijms252011112"},{"key":"7302_CR31","doi-asserted-by":"publisher","first-page":"123095","DOI":"10.1016\/j.lfs.2024.123095","volume":"357","author":"YY Shu","year":"2024","unstructured":"Shu YY, et al. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier. Life Sci. 2024;357:123095.","journal-title":"Life Sci"},{"issue":"4","key":"7302_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/abbs\/gmt143","volume":"46","author":"W Chang","year":"2014","unstructured":"Chang W, et al. Isolation and culture of hepatic stellate cells from mouse liver. Acta Biochim Biophys Sin (Shanghai). 2014;46(4):291\u20138.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"7302_CR33","doi-asserted-by":"publisher","first-page":"2267416","DOI":"10.1080\/19336950.2023.2267416","volume":"17","author":"L Wu","year":"2023","unstructured":"Wu L, Chen J. Type 3 IP3 receptor: its structure, functions, and related disease implications. Channels (Austin). 2023;17(1):2267416.","journal-title":"Channels (Austin)"},{"issue":"2","key":"7302_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ymthe.2021.06.024","volume":"30","author":"A Verma","year":"2022","unstructured":"Verma A, et al. The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target. Mol Ther. 2022;30(2):726\u201344.","journal-title":"Mol Ther"},{"issue":"23","key":"7302_CR35","doi-asserted-by":"publisher","first-page":"e2416489","DOI":"10.1002\/advs.202416489","volume":"12","author":"Y Lu","year":"2025","unstructured":"Lu Y, et al. Gelsolin\u2019s protective role in MASH through F-Actin regulation and P53 degradation. Adv Sci (Weinh). 2025;12(23):e2416489.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"7302_CR36","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.xcrm.2024.101477","volume":"5","author":"W Zhu","year":"2024","unstructured":"Zhu W, et al. Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation. Cell Rep Med. 2024;5(3):101477.","journal-title":"Cell Rep Med"},{"issue":"4","key":"7302_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu B, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2018;68(4):773\u201382.","journal-title":"J Hepatol"},{"issue":"7","key":"7302_CR38","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.7150\/thno.69826","volume":"12","author":"N Ding","year":"2022","unstructured":"Ding N, et al. AGK regulates the progression to NASH by affecting mitochondria complex I function. Theranostics. 2022;12(7):3237\u201350.","journal-title":"Theranostics"},{"key":"7302_CR39","doi-asserted-by":"publisher","first-page":"155380","DOI":"10.1016\/j.metabol.2022.155380","volume":"140","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway. Metabolism. 2023;140:155380.","journal-title":"Metabolism"},{"issue":"9","key":"7302_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-018-0059-z","volume":"15","author":"A Picca","year":"2018","unstructured":"Picca A, et al. Mitochondrial quality control mechanisms as molecular targets in cardiac ageing. Nat Rev Cardiol. 2018;15(9):543\u201354.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"7302_CR41","doi-asserted-by":"publisher","first-page":"e00368","DOI":"10.1016\/j.neurot.2024.e00368","volume":"21","author":"Q Li","year":"2024","unstructured":"Li Q, et al. Oxidized mitochondrial DNA activates the cGAS-STING pathway in the neuronal intrinsic immune system after brain ischemia-reperfusion injury. Neurotherapeutics. 2024;21(4):e00368.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"7302_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17474086.2024.2391102","volume":"17","author":"Z Eftekhar","year":"2024","unstructured":"Eftekhar Z, Aghaei M, Saki N. DNA damage repair in megakaryopoiesis: molecular and clinical aspects. Expert Rev Hematol. 2024;17(10):705\u201312.","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"7302_CR43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.it.2023.01.006","volume":"44","author":"H Xian","year":"2023","unstructured":"Xian H, Karin M. Oxidized mitochondrial DNA: a protective signal gone awry. Trends Immunol. 2023;44(3):188\u2013200.","journal-title":"Trends Immunol"},{"key":"7302_CR44","doi-asserted-by":"crossref","unstructured":"McArthur K et al. BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science, 2018;359(6378).","DOI":"10.1126\/science.aao6047"},{"key":"7302_CR45","doi-asserted-by":"publisher","first-page":"102132","DOI":"10.1016\/j.ceca.2019.102132","volume":"85","author":"A Mangla","year":"2020","unstructured":"Mangla A, Guerra MT, Nathanson MH. Type 3 inositol 1,4,5-trisphosphate receptor: A calcium channel for all seasons. Cell Calcium. 2020;85:102132.","journal-title":"Cell Calcium"},{"issue":"1","key":"7302_CR46","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","volume":"12","author":"Y Xue","year":"2021","unstructured":"Xue Y, et al. SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria. Nat Commun. 2021;12(1):5404.","journal-title":"Nat Commun"},{"issue":"11","key":"7302_CR47","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan H, et al. Hexokinase 2 senses Fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metab. 2024;36(11):2449\u201367. .e6.","journal-title":"Cell Metab"},{"issue":"9","key":"7302_CR48","doi-asserted-by":"publisher","first-page":"e70083","DOI":"10.1002\/hsr2.70083","volume":"7","author":"E Torfi","year":"2024","unstructured":"Torfi E, et al. Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case-control study. Health Sci Rep. 2024;7(9):e70083.","journal-title":"Health Sci Rep"},{"key":"7302_CR49","doi-asserted-by":"publisher","first-page":"155758","DOI":"10.1016\/j.phymed.2024.155758","volume":"131","author":"L Ren","year":"2024","unstructured":"Ren L, et al. Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein. Phytomedicine. 2024;131:155758.","journal-title":"Phytomedicine"},{"key":"7302_CR50","doi-asserted-by":"publisher","first-page":"105384","DOI":"10.1016\/j.phrs.2020.105384","volume":"164","author":"H Liu","year":"2021","unstructured":"Liu H, et al. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacol Res. 2021;164:105384.","journal-title":"Pharmacol Res"},{"issue":"1","key":"7302_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jtcme.2024.03.005","volume":"15","author":"J Yu","year":"2025","unstructured":"Yu J, et al. Zhongfeng Xingnao prescription alleviates injury of intracerebral hemorrhage via regulating the CaMKII\/NF-\u03baB p65\/NLRP3\/GSDMD signaling axis. J Tradit Complement Med. 2025;15(1):84\u201392.","journal-title":"J Tradit Complement Med"},{"issue":"12","key":"7302_CR52","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1136\/gutjnl-2021-325013","volume":"71","author":"MU Latif","year":"2022","unstructured":"Latif MU, et al. NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. Gut. 2022;71(12):2561\u201373.","journal-title":"Gut"},{"issue":"7","key":"7302_CR53","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"3","key":"7302_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11864-025-01295-8","volume":"26","author":"F Karimi","year":"2025","unstructured":"Karimi F, Aghaei M, Saki N. Impact of genetic polymorphisms on treatment outcomes of proteasome inhibitors and Immunomodulatory drugs in multiple myeloma. Curr Treat Options Oncol. 2025;26(3):197\u2013212.","journal-title":"Curr Treat Options Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:03:36Z","timestamp":1763172216000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7302"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07302-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Humane care guided by the guidelines of the National Institutes of Health was provided to all animals. All mice were raised under specific pathogen-free conditions, following the procedures approved by the Animal Use and Ethics Committee of the 2nd Affiliated Hospital of Chongqing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1289"}}